ATI Pathophysiology Final Exam Related

Review ATI Pathophysiology Final Exam related questions and content

A hospital patient's complex medical history includes a recent diagnosis of kidney cancer. Which of the following medications is used to treat metastatic kidney cancer?

  • A. Filgrastim (Neupogen)
  • B. Aldesleukin (Proleukin)
  • C. Interferon alfa-2b (Intron A)
  • D. Darbepoetin alfa (Aranesp)
Correct Answer: B

Rationale: The correct answer is B: Aldesleukin (Proleukin). Aldesleukin is a medication used in the treatment of metastatic kidney cancer. It is a recombinant interleukin-2 that works by stimulating the immune system to attack cancer cells. Choice A, Filgrastim, is a medication used to stimulate the production of white blood cells. Choice C, Interferon alfa-2b, is used in the treatment of certain cancers but not specifically metastatic kidney cancer. Choice D, Darbepoetin alfa, is used to treat anemia by stimulating red blood cell production and is not indicated for metastatic kidney cancer.